Skip to main content

Zika virus associated with 1 in 100 risk of microcephaly, says study

Zika virus associated with 1 in 100 risk of microcephaly, says study

Share this story

Women infected with the Zika virus during the first trimester of pregnancy face a roughly 1 in 100 chance that their unborn child will develop the serious birth defect microcephaly. This is according to a new study published earlier this week in The Lancet, which is the first to give a concrete estimate of the risks associated with the virus.

The study confirms that the dangers associated with Zika are low compared to other viral infections. A one percent risk contrasts favorably with a 13 percent risk of complications for cytomegalovirus, or the 38 to 100 percent risk of conditions including heart abnormalities and hearing loss for rubella infections. However, because Zika can be spread so widely in populations by mosquitoes, it poses a serious threat. "If you apply a one percent risk to a large number of women, it’s still a large public health problem," Simon Cauchemez, the study’s lead author told The New York Times.

The exact connection between the zika vius and microcephaly is still unknown

The study itself looked at the prevalence of birth defects during a recent outbreak of the Zika virus in French Polynesia. The region has a small population — around 270,000 — making it easy for researchers to collect all the relevant cases. During the outbreak between 2013 and 2015 there were eight cases of microcephaly, with seven of these occurring over the last four months of this period. This clustering, say the researchers, strongly supports the proposed association between the virus and the birth defect, although the exact mechanism that's at work is still unknown.

The researchers used this data and statistical modeling to create the estimated risks associated with Zika. However, the study does not take into account other abnormalities that may be associated with the virus, and its authors warn that the risk may differ from outbreak to outbreak. Speaking to The Wall Street Journal, the study's co-author Arnaud Fontanet said: "The one percent we describe here is not the end of the story."